antipyrine has been researched along with Vestibular Diseases in 2 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Streptomycin was administered to the inner ear by osmotic pump for 24 h, and edaravone (n=8) or saline (n=6) was intraperitoneally injected once a day for 7 days." | 1.32 | Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig. ( Horiike, O; Ikeda, T; Shimogori, H; Yamashita, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiike, O | 1 |
| Shimogori, H | 2 |
| Ikeda, T | 1 |
| Yamashita, H | 2 |
| Takemoto, T | 1 |
| Mikuriya, T | 1 |
2 other studies available for antipyrine and Vestibular Diseases
| Article | Year |
|---|---|
Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig.
Topics: Animals; Antipyrine; Edaravone; Guinea Pigs; Male; Nystagmus, Physiologic; Protective Agents; Reflex | 2003 |
Edaravone protects the vestibular periphery from free radical-induced toxicity in response to perilymphatic application of (+/-)-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid.
Topics: Aldehydes; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipyrine; Edaravone; | 2007 |